Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Palix Foundation has pledged £265,250 to support a cross-disciplinary project aimed at sharing scientific knowledge about early brain development and its effect on mental health and addiction. The project will be delivered by the Department of Psychiatry and the Department of Experimental Psychology, and will unite Oxford and the foundation's shared vision of improving outcomes for children, their families and future generations.

© THE BRAIN STORY © PALIX FOUNDATION / ALBERTA FAMILY WELLNESS INITIATIVE

Lifelong health is determined by more than just our genes: experiences early in life and at other sensitive periods of development can affect our brains in ways that may impact our health as we grow older. This knowledge has important implications for both policy and practice, but despite its significance, the science behind early brain development is not widely disseminated. Front-line staff may be unfamiliar with recent advances in the field, while parents have little exposure to the science underlying the growth of their children's brains.

The Palix Foundation seeks to bridge this gap. In 2010 the foundation began disseminating the Brain Story, a narrative framework that makes scientific knowledge about early brain development accessible to policy-makers, practitioners and the public. Developed by the FrameWorks Institute and the National Scientific Council of the Developing Child, the Brain Story is shared via tools, resources and a certification course, with the aim of building resilience in families and communities around the world.

With the foundation's support, a team of researchers at Oxford will now work to embed the Brain Story locally and beyond. Under the leadership of Alan Stein, Professor of Child and Adolescent Psychiatry at the University, the team will develop a programme to explore and evaluate different ways of implementing the Brain Story, thus maximising its reach and impact.

Read more (University of Oxford Development Office)

Similar stories

Long COVID: vaccination could reduce symptoms, new research suggests

While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.